Abstract

Moving Research From Bench to Bedside to Community: There Is Still More to Do

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
...
The Lancet | VOL. 366
, et. al. ...
01 Dec 2005
Aromatase Inhibitors in Adjuvant Therapy of Breast Cancer: Before, Instead of, or Beyond Tamoxifen
Kathleen I Pritchard
Journal of Clinical Oncology | VOL. 23
Kathleen I PritchardKathleen I Pritchard
11 Jul 2005
Advances in Screening, Diagnosis, and Treatment of Breast Cancer
Betty A Mincey ... Edith A Perez
Mayo Clinic Proceedings | VOL. 79
Betty A Mincey, et. al.Betty A Mincey ... Edith A Perez
01 Jun 2004
Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies.
Kathleen I Pritchard ... David Cameron
Journal of clinical oncology : official journal of the American Society of Clinical Oncology | VOL. 34
Kathleen I Pritchard, et. al.Kathleen I Pritchard ... David Cameron
19 Jan 2016
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers